Insulin-like growth factor binding protein-6 released from human mesenchymal stem cells confers neuronal protection through IGF-1R-mediated signaling

Jeon,Hyo-Jin; Park,Jihye; Shin,Joo-Hyun; Chang,Mi-Sook

doi:10.3892/ijmm.2017.3173

Insulin-like growth factor binding protein-6 released from human mesenchymal stem cells confers neuronal protection through IGF-1R-mediated signaling

Authors:
- Hyo-Jin Jeon
- Jihye Park
- Joo-Hyun Shin
- Mi-Sook Chang
View Affiliations

Affiliations: Laboratory of Stem Cell and Neurobiology, Department of Oral Anatomy, School of Dentistry and Dental Research Institute, Seoul National University, Seoul 03080, Republic of Korea
Published online on: October 5, 2017 https://doi.org/10.3892/ijmm.2017.3173
Pages: 1860-1868
Copyright: © Jeon et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Human bone marrow‑derived mesenchymal stem cells (hMSCs) are a desirable cell source for cell‑based therapy to treat nervous system injuries due to their ability to differentiate into specific cell types. In addition to their multipotency, hMSCs render the tissue microenvironment more favorable for tissue repair by secreting various growth factors. Our previous study demonstrated that hMSCs secrete several growth factors, including several insulin‑like growth factor binding proteins (IGFBPs). Among these, IGFBP‑6 binds with high affinity and inhibits insulin growth factor‑2 (IGF‑2) to inhibit the growth of IGF‑2‑dependent tumors. However, the function of IGFBP‑6 in the nervous system remains to be fully elucidated. The present study investigated the protective effects of IGFBP‑6 secreted by hMSCs on H2O2‑injured primary cortical neuron cultures and lysolecithin‑injured organotypic spinal cord slice cultures. Treatment of the H2O2‑injured cortical neurons with conditioned media from hMSCs (hMSC‑CM) increased the phosphorylation of Akt, reduced cell death and mitochondrial translocation of Bax, and regulated extracellular levels of IGF‑1 and IGF‑2. MTT assay, western blot analysis and ELISA were used to detect the cell viability and protein expression levels, respectively. An inhibitory antibody against IGFBP‑6 eliminated this hMSC‑CM‑mediated neuroprotective effect in the injured cortical neuron cultures and spinal cord slice cultures. In addition, treatment with cyclolignan picropodophyllin, an inhibitor of IGF‑1 receptor (IGF‑1R), significantly inhibited neuronal protection by hMSC‑CM. These findings demonstrated that hMSC‑CM‑mediated neuroprotection was attributed to IGF‑1R‑mediated signaling, potentiated via the inhibition of IGF‑2 by IGFBP‑6. The results of the present study provide insight into the mechanism by which hMSC administration may promote recovery from nerve injury.

View Figures

View References

1	Reynolds A, Laurie C, Mosley RL and Gendelman HE: Oxidative stress and the pathogenesis of neurodegenerative disorders. Int Rev Neurobiol. 82:297–325. 2007. View Article : Google Scholar : PubMed/NCBI
2	Uttara B, Singh AV, Zamboni P and Mahajan RT: Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 7:65–74. 2009. View Article : Google Scholar : PubMed/NCBI
3	Uccelli A, Moretta L and Pistoia V: Mesenchymal stem cells in health and disease. Nat Rev Immunol. 8:726–736. 2008. View Article : Google Scholar
4	Mezey E: The therapeutic potential of bone marrow-derived stromal cells. J Cell Biochem. 112:2683–2687. 2011. View Article : Google Scholar : PubMed/NCBI
5	Park HW, Lim MJ, Jung H, Lee SP, Paik KS and Chang MS: Human mesenchymal stem cell-derived Schwann cell-like cells exhibit neurotrophic effects, via distinct growth factor production, in a model of spinal cord injury. Glia. 58:1118–1132. 2010. View Article : Google Scholar : PubMed/NCBI
6	Firth SM and Baxter RC: Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev. 23:824–854. 2002. View Article : Google Scholar : PubMed/NCBI
7	Hwa V, Oh Y and Rosenfeld RG: The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev. 20:761–787. 1999.PubMed/NCBI
8	Hoyt KR, Gallagher AJ, Hastings TG and Reynolds IJ: Characterization of hydrogen peroxide toxicity in cultured rat forebrain neurons. Neurochem Res. 22:333–340. 1997. View Article : Google Scholar : PubMed/NCBI
9	Bach LA: Recent insights into the actions of IGFBP-6. J Cell Commun Signal. 9:189–200. 2015. View Article : Google Scholar : PubMed/NCBI
10	Oskowitz A, McFerrin H, Gutschow M, Carter ML and Pochampally R: Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic. Stem Cell Res. 6:215–225. 2011. View Article : Google Scholar : PubMed/NCBI
11	Koike H, Ito K, Takezawa Y, Oyama T, Yamanaka H and Suzuki K: Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: Implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer. Br J Cancer. 92:1538–1544. 2005. View Article : Google Scholar : PubMed/NCBI
12	Cohen DM: Urea-inducible Egr-1 transcription in renal inner medullary collecting duct (mIMCD3) cells is mediated by extracellular signal-regulated kinase activation. Proc Natl Acad Sci USA. 93:11242–11247. 1996. View Article : Google Scholar : PubMed/NCBI
13	Wu EH and Wong YH: Involvement of Gi/o proteins in nerve growth factor-stimulated phosphorylation and degradation of tuberin in PC-12 cells and cortical neurons. Mol Pharmacol. 67:1195–1205. 2005. View Article : Google Scholar : PubMed/NCBI
14	Wahane SD, Hellbach N, Prentzell MT, Weise SC, Vezzali R, Kreutz C, Timmer J, Krieglstein K, Thedieck K and Vogel T: PI3K-p110-alpha-subtype signalling mediates survival, proliferation and neurogenesis of cortical progenitor cells via activation of mTORC2. J Neurochem. 130:255–267. 2014. View Article : Google Scholar : PubMed/NCBI
15	Cho JS, Park H-W, Park S-K, Roh S, Kang SK, Paik KS and Chang MS: Transplantation of mesenchymal stem cells enhances axonal outgrowth and cell survival in an organotypic spinal cord slice culture. Neurosci Lett. 454:43–48. 2009. View Article : Google Scholar : PubMed/NCBI
16	Saltiel AR and Kahn CR: Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 414:799–806. 2001. View Article : Google Scholar : PubMed/NCBI
17	Pang Y, Zheng B, Fan LW, Rhodes PG and Cai Z: IGF-1 protects oligodendrocyte progenitors against TNFalpha-induced damage by activation of PI3K/Akt and interruption of the mitochondrial apoptotic pathway. Glia. 55:1099–1107. 2007. View Article : Google Scholar : PubMed/NCBI
18	Wolter KG, Hsu Y-T, Smith CL, Nechushtan A, Xi XG and Youle RJ: Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol. 139:1281–1292. 1997. View Article : Google Scholar
19	Hsu YT, Wolter KG and Youle RJ: Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc Natl Acad Sci USA. 94:3668–3672. 1997. View Article : Google Scholar : PubMed/NCBI
20	Ljubisavljevic S: Oxidative stress and neurobiology of demyelination. Mol Neurobiol. 53:744–758. 2016. View Article : Google Scholar
21	Crigler L, Robey RC, Asawachaicharn A, Gaupp D and Phinney DG: Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol. 198:54–64. 2006. View Article : Google Scholar
22	Nakano N, Nakai Y, Seo T-B, Yamada Y, Ohno T, Yamanaka A, Nagai Y, Fukushima M, Suzuki Y, Nakatani T, et al: Characterization of conditioned medium of cultured bone marrow stromal cells. Neurosci Lett. 483:57–61. 2010. View Article : Google Scholar : PubMed/NCBI
23	Micutkova L, Diener T, Li C, Rogowska-Wrzesinska A, Mueck C, Huetter E, Weinberger B, Grubeck-Loebenstein B, Roepstorff P, Zeng R, et al: Insulin-like growth factor binding protein-6 delays replicative senescence of human fibroblasts. Mech Ageing Dev. 132:468–479. 2011. View Article : Google Scholar : PubMed/NCBI
24	Schmid C, Keller C, Gosteli-Peter M and Zapf J: Mitogenic and antiapoptotic effects of insulin-like growth factor binding protein-6 in the human osteoblastic osteosarcoma cell line Saos-2/B-10. Biochem Biophys Res Commun. 263:786–789. 1999. View Article : Google Scholar : PubMed/NCBI
25	Brunet A, Datta SR and Greenberg ME: Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol. 11:297–305. 2001. View Article : Google Scholar : PubMed/NCBI
26	Yamaguchi A, Tamatani M, Matsuzaki H, Namikawa K, Kiyama H, Vitek MP, Mitsuda N and Tohyama M: Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53. J Biol Chem. 276:5256–5264. 2001. View Article : Google Scholar
27	Beilharz EJ, Russo VC, Butler G, Baker NL, Connor B, Sirimanne ES, Dragunow M, Werther GA, Gluckman PD, Williams CE, et al: Co-ordinated and cellular specific induction of the components of the IGF/IGFBP axis in the rat brain following hypoxic-ischemic injury. Brain Res Mol Brain Res. 59:119–134. 1998. View Article : Google Scholar : PubMed/NCBI
28	Guan J, Williams CE, Skinner SJ, Mallard EC and Gluckman PD: The effects of insulin-like growth factor (IGF)-1, IGF-2, and des-IGF-1 on neuronal loss after hypoxic-ischemic brain injury in adult rats: Evidence for a role for IGF binding proteins. Endocrinology. 137:893–898. 1996. View Article : Google Scholar : PubMed/NCBI
29	Chesik D, De Keyser J and Wilczak N: Insulin-like growth factor binding protein-2 as a regulator of IGF actions in CNS: Implications in multiple sclerosis. Cytokine Growth Factor Rev. 18:267–278. 2007. View Article : Google Scholar : PubMed/NCBI
30	LeRoith D, Werner H, Beitner-Johnson D and Roberts CT Jr: Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev. 16:143–163. 1995. View Article : Google Scholar : PubMed/NCBI
31	Yoon JW, Kita Y, Frank DJ, Majewski RR, Konicek BA, Nobrega MA, Jacob H, Walterhouse D and Iannaccone P: Gene expression profiling leads to identification of GLI1 binding elements in target genes and a role for multiple downstream pathways in GLI1 induced cell transformation. J Biol Chem. 277:5548–5555. 2002. View Article : Google Scholar
32	Xu XF, Guo C-Y, Liu J, Yang WJ, Xia YJ, Xu L, Yu YC and Wang XP: Gli1 maintains cell survival by up-regulating IGFBP6 and Bcl-2 through promoter regions in parallel manner in pancreatic cancer cells. J Carcinog. 8:132009. View Article : Google Scholar : PubMed/NCBI
33	Agarwal NK, Qu C, Kunkalla K, Liu Y and Vega F: Transcriptional regulation of serine/threonine protein kinase (AKT) genes by glioma-associated oncogene homolog 1. J Biol Chem. 288:15390–15401. 2013. View Article : Google Scholar : PubMed/NCBI
34	Duan C and Xu Q: Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions. Gen Comp Endocrinol. 142:44–52. 2005. View Article : Google Scholar : PubMed/NCBI